Inspire Investing LLC Cuts Stock Holdings in DaVita Inc. (NYSE:DVA)

Inspire Investing LLC trimmed its stake in shares of DaVita Inc. (NYSE:DVA) by 13.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,608 shares of the company’s stock after selling 844 shares during the period. Inspire Investing LLC’s holdings in DaVita were worth $777,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Blue Trust Inc. grew its stake in DaVita by 58.6% during the second quarter. Blue Trust Inc. now owns 211 shares of the company’s stock valued at $29,000 after acquiring an additional 78 shares in the last quarter. Wedmont Private Capital grew its stake in shares of DaVita by 6.0% in the 2nd quarter. Wedmont Private Capital now owns 1,701 shares of the company’s stock worth $241,000 after buying an additional 96 shares in the last quarter. First Trust Direct Indexing L.P. grew its stake in shares of DaVita by 3.9% in the 1st quarter. First Trust Direct Indexing L.P. now owns 2,590 shares of the company’s stock worth $358,000 after buying an additional 98 shares in the last quarter. Quent Capital LLC grew its stake in shares of DaVita by 21.0% in the 1st quarter. Quent Capital LLC now owns 581 shares of the company’s stock worth $80,000 after buying an additional 101 shares in the last quarter. Finally, GAMMA Investing LLC grew its stake in shares of DaVita by 18.8% in the 1st quarter. GAMMA Investing LLC now owns 657 shares of the company’s stock worth $91,000 after buying an additional 104 shares in the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at DaVita

In related news, CEO Javier Rodriguez sold 32,176 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $155.93, for a total value of $5,017,203.68. Following the completion of the sale, the chief executive officer now owns 905,659 shares in the company, valued at $141,219,407.87. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other DaVita news, CEO Javier Rodriguez sold 32,176 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $155.93, for a total transaction of $5,017,203.68. Following the completion of the sale, the chief executive officer now owns 905,659 shares in the company, valued at $141,219,407.87. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, COO Michael David Staffieri sold 9,539 shares of the company’s stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $150.03, for a total value of $1,431,136.17. Following the sale, the chief operating officer now owns 241,945 shares of the company’s stock, valued at approximately $36,299,008.35. The disclosure for this sale can be found here. Over the last quarter, insiders sold 173,482 shares of company stock worth $27,387,069. Company insiders own 2.00% of the company’s stock.

DaVita Trading Up 0.5 %

DVA opened at $164.00 on Friday. The stock has a market cap of $14.38 billion, a price-to-earnings ratio of 18.64, a P/E/G ratio of 0.95 and a beta of 0.87. The stock’s 50 day moving average price is $147.19 and its 200-day moving average price is $140.85. DaVita Inc. has a one year low of $71.51 and a one year high of $166.04. The company has a debt-to-equity ratio of 9.94, a quick ratio of 1.12 and a current ratio of 1.16.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $2.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.47 by $0.12. The firm had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.15 billion. DaVita had a return on equity of 77.00% and a net margin of 6.86%. DaVita’s quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.08 earnings per share. On average, equities analysts forecast that DaVita Inc. will post 9.99 EPS for the current year.

Analyst Ratings Changes

DVA has been the subject of a number of recent research reports. Truist Financial lifted their price objective on shares of DaVita from $150.00 to $165.00 and gave the stock a “hold” rating in a research note on Tuesday, August 20th. Bank of America lifted their price objective on shares of DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a research note on Wednesday, August 7th. TD Cowen upped their price target on shares of DaVita from $139.00 to $150.00 and gave the company a “hold” rating in a report on Wednesday, July 24th. StockNews.com downgraded shares of DaVita from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 8th. Finally, UBS Group upped their target price on DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, DaVita currently has an average rating of “Hold” and an average price target of $157.00.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.